Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Biochim Biophys Acta Mol Cell Biol Lipids. 2021 May 10;1866(8):158964. doi: 10.1016/j.bbalip.2021.158964

Figure 2. Expression of E-FABP and A-FABP in different subsets of TAMs.

Figure 2

E-FABP expression in TAMs exerts anti-tumor effects by promoting type I IFNβ signaling and adaptive immune responses, while TAM expression of A-FABP promotes tumor progression by enhancing pro-tumor IL-6/STAT3 signaling.